• Hormonal regulation shapes myometrial excitability and contractile responsiveness, with estrogens increasing membrane potential and progesterone modulating ATPase activity and overall excitability across pregnancy and labor [13], [3], [17], [7].

• Pharmacologic and receptor-mediated modulation of uterine contractions emerge as a core paradigm, including adrenergic blockade, oxytocic stimulation, and calcium-dependence in in vitro and in situ models [11], [18], [6], [20].

• Electrical signaling and ion-channel dynamics underlie uterine activity, highlighted by intracellular membrane-potential recordings, pregnancy-related shifts, and calcium dependence of contractile responses [7], [13], [20].

• Endocrine milieu and vascular context modulate contractility, evidenced by uterine blood flow assessments, venous progesterone during gestation, and luminal fluid composition shaping local uterine conditions [19], [5], [10].

• Protein-level and enzymatic components of the contractile apparatus receive attention, with characterization of uterine contractile proteins and extracellular remodeling enzymes as potential regulators of force generation [1], [15].

• Labor- and delivery-stage regulation emphasizes functional changes of the myometrium, integrating core contractile physiology with systemic hormonal control during delivery and puerperium [9], [4], [3].